58468-0200 : Lemtrada 12 mg/1.2ml Intravenous Injection, Solution, Concentrate
NDC: | 58468-0200 |
Labeler: | Genzyme Corporation |
Product Type: | Human Prescription Drug |
Drug Name: | Lemtrada |
Dosage Form: | Intravenous Injection, Solution, Concentrate |
Application #: | BLA103948 |
Rev. Date: |
NDC Package Codes:
- 58468-0200-1: 1 VIAL, SINGLE‑USE IN 1 CARTON (58468‑0200‑1) > 2 ML IN 1 VIAL, SINGLE‑USE
Active Ingredients:
- Alemtuzumab
Dosage Strength:
- 12 mg/1.2mL
Pharmaceutical Classes:
- CD52-directed Antibody Interactions [MoA]
- CD52-directed Cytolytic Antibody [EPC]
NDC QR Code
Scan the QR code below to easily reference this data in the future:< Prev: 58468-0191Next: 58468-0210 >
Related Discussions:
IBM ALEMTUZUMAB
IBM TREATMENT THROUGH alemtuzumab...
IBM TREATMENT THROUGH alemtuzumab...
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.